| HOME >> BIOLOGY >> TECHNOLOGY |
ST. JOSEPH, Mich., March 24 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London (BRC-MH), has joined the MetaMiner CNS Partnership Program. Professor Simon Lovestone, Centre Director, and Dr. Gerome Breen are leading the BRC-MH team for this project. The goal of the program is to develop a proprietary Central Nervous System (CNS) pathway analysis platform built by experts in the field. This includes developing a series of blueprint CNS disease pathway maps for Schizophrenia, Alzheimer's disease and Huntington's disease, etc. as well as collecting experimental data from the public domain, and making it available for analysis.
Professor Lovestone said: "This is an important initiative as it will give researchers a global perspective of CNS pathways and enable those new to the field to get up to speed quickly. Currently there is a huge amount of CNS data available but until now no one has brought it all together in a comprehensive form."
Dr. Breen, BRC-MH Genetics Coordinator, adds, "Accurate and comprehensive pathway annotation is necessary for us to discern the biological mechanisms revealed by large scale omics approaches to CNS disorders, such as genomewide association and expression array studies."
Julie Bryant, GeneGo's VP of Business Development, comments, "The BRC-MH at KCL has world class expertise in CNS disorders and we are pleased to have the Centre on our team. We plan to develop excellent and accurately annotated CNS pathway maps, while fully processing experimental data taken from public repositories such as GEO. This will ultimately mean superior CNS pathway annotation and facilitate easier data analysis and exploration for our customers."
'/>"/>
| SOURCE GeneGo, Inc. Copyright©2009 PR Newswire. All rights reserved |